Darren Dasburg | CEO, Clarus Biologics – Advancing Vaccine and Immunology Innovation with Novel Adjuvant Platforms
Update: 2025-09-08
Description
In this episode of Executive Insights for Life Sciences Innovators, we sit down with Darren Dasburg, CEO of Clarus Biologics, a company advancing vaccine and immunology innovation through a novel adjuvant platform designed to improve immune responses, particularly in vulnerable populations. Darren shares insights on Clarus Biologics’ technology, its potential applications in global health, and the company’s strategy for bringing novel adjuvant solutions to market.
Learn more at genecoda.com.
Originally recorded and streamed on YouTube Live on May 19, 2025.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
